199 related articles for article (PubMed ID: 9655870)
1. Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor.
Alt A; Mansour A; Akil H; Medzihradsky F; Traynor JR; Woods JH
J Pharmacol Exp Ther; 1998 Jul; 286(1):282-8. PubMed ID: 9655870
[TBL] [Abstract][Full Text] [Related]
2. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.
Emmerson PJ; Clark MJ; Mansour A; Akil H; Woods JH; Medzihradsky F
J Pharmacol Exp Ther; 1996 Sep; 278(3):1121-7. PubMed ID: 8819494
[TBL] [Abstract][Full Text] [Related]
3. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
Traynor JR; Nahorski SR
Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus.
Selley DE; Liu Q; Childers SR
J Pharmacol Exp Ther; 1998 May; 285(2):496-505. PubMed ID: 9580589
[TBL] [Abstract][Full Text] [Related]
6. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla.
Mizoguchi H; Narita M; Wu H; Narita M; Suzuki T; Nagase H; Tseng LF
Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217
[TBL] [Abstract][Full Text] [Related]
7. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
8. Binding studies of novel, non-mammalian enkephalins, structures predicted from frog and lungfish brain cDNA sequences.
Bojnik E; Magyar A; Tóth G; Bajusz S; Borsodi A; Benyhe S
Neuroscience; 2009 Jan; 158(2):867-74. PubMed ID: 18977279
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
[TBL] [Abstract][Full Text] [Related]
10. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
11. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
12. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats.
Chen F; Lawrence AJ
J Pharmacol Exp Ther; 2004 Sep; 310(3):1020-6. PubMed ID: 15121763
[TBL] [Abstract][Full Text] [Related]
13. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
Szekeres PG; Traynor JR
J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003
[TBL] [Abstract][Full Text] [Related]
14. mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy.
Selley DE; Sim LJ; Xiao R; Liu Q; Childers SR
Mol Pharmacol; 1997 Jan; 51(1):87-96. PubMed ID: 9016350
[TBL] [Abstract][Full Text] [Related]
15. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections.
Martin TJ; Sim LJ; Selley DE; deMontis MG; Childers SR
Synapse; 1997 Nov; 27(3):177-82. PubMed ID: 9329153
[TBL] [Abstract][Full Text] [Related]
16. Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain.
Saland LC; Abeyta A; Frausto S; Raymond-Stintz M; Hastings CM; Carta M; Valenzuela CF; Savage DD
Alcohol Clin Exp Res; 2004 Jan; 28(1):98-104. PubMed ID: 14745307
[TBL] [Abstract][Full Text] [Related]
17. [Effects of newly isolated opioid peptides on G-protein activation: usefulness of [35S] GTP gamma S binding study and its practical application].
Narita M
Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Aug; 18(4):107-16. PubMed ID: 9866825
[TBL] [Abstract][Full Text] [Related]
18. Opioids binding mu and delta receptors exhibit diverse efficacy in the activation of Gi2 and G(x/z) transducer proteins in mouse periaqueductal gray matter.
Garzón J; García-España A; Sánchez-Blázquez P
J Pharmacol Exp Ther; 1997 Apr; 281(1):549-57. PubMed ID: 9103543
[TBL] [Abstract][Full Text] [Related]
19. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.
Clark MJ; Emmerson PJ; Mansour A; Akil H; Woods JH; Portoghese PS; Remmers AE; Medzihradsky F
J Pharmacol Exp Ther; 1997 Nov; 283(2):501-10. PubMed ID: 9353363
[TBL] [Abstract][Full Text] [Related]
20. Mu-delta opioid receptor functional interaction: Insight using receptor-G protein fusions.
Snook LA; Milligan G; Kieffer BL; Massotte D
J Pharmacol Exp Ther; 2006 Aug; 318(2):683-90. PubMed ID: 16690720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]